Table 2.
Seroprevalence according to time since vaccine receipt
| Quintile | Time since vaccine receipt | n/N | Seroprevalence |
|---|---|---|---|
| Q1 | 1–9 days | 20/125 | 16.00% |
| Q2 | 10–18 days | 91/123 | 73.98% |
| Q3 | 19–28 days | 120/122 | 98.36% |
| Q4 | 29–46 days | 126/129 | 97.67% |
| Q5 | 47–117 days | 119/121 | 98.35% |